[go: up one dir, main page]

AR020650A1 - Polimeros fosforilados y conjugados de los mismos - Google Patents

Polimeros fosforilados y conjugados de los mismos

Info

Publication number
AR020650A1
AR020650A1 ARP990103971A ARP990103971A AR020650A1 AR 020650 A1 AR020650 A1 AR 020650A1 AR P990103971 A ARP990103971 A AR P990103971A AR P990103971 A ARP990103971 A AR P990103971A AR 020650 A1 AR020650 A1 AR 020650A1
Authority
AR
Argentina
Prior art keywords
phosphoriled
same
conjugated polymers
conjugate
peptide
Prior art date
Application number
ARP990103971A
Other languages
English (en)
Original Assignee
Poly Med Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poly Med Inc filed Critical Poly Med Inc
Publication of AR020650A1 publication Critical patent/AR020650A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)

Abstract

Poliésteres absorbibles que comprenden uno o más funcionalidades monofosfato; un conjugado que comprende el poliéster precedente y un péptido y/o un agentebioactivo; micropartículas que comprenden un poliéster absorbible; un conjugado que comprendel as micropartículas y un péptido y/o un agente bioactivo; unpolisacárido acilado o alquilado que tiene una o más funcionalidad monofosfato; un conjugado que comprende un polisacárido acilado o alquilado y un péptido y/oun agente bioactivo; ycomposici ones farmacéuticas de los mismos.
ARP990103971A 1998-08-10 1999-08-09 Polimeros fosforilados y conjugados de los mismos AR020650A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9587598P 1998-08-10 1998-08-10
US13147298A 1998-08-10 1998-08-10

Publications (1)

Publication Number Publication Date
AR020650A1 true AR020650A1 (es) 2002-05-22

Family

ID=26790709

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103971A AR020650A1 (es) 1998-08-10 1999-08-09 Polimeros fosforilados y conjugados de los mismos

Country Status (11)

Country Link
EP (1) EP1105161B1 (es)
JP (1) JP2002522596A (es)
AR (1) AR020650A1 (es)
AT (1) ATE390935T1 (es)
AU (1) AU5475599A (es)
CA (1) CA2339143A1 (es)
DE (1) DE69938453D1 (es)
NO (1) NO20010682L (es)
PL (1) PL346758A1 (es)
RU (1) RU2202563C2 (es)
WO (1) WO2000009166A2 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7083634B2 (en) * 1998-11-12 2006-08-01 Poly Med Inc Stabilized polyester/cyanoacrylate tissue adhesive formulation
EP1348444B1 (en) * 1999-08-18 2006-04-12 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Sustained release formulation of a peptide complexed with a polymer
KR20020031407A (ko) * 1999-08-18 2002-05-01 다푸르 가브리에 펩타이드의 서방형 제제
US7109166B1 (en) 1999-08-18 2006-09-19 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Sustained release formulation of a peptide
EP1711523B1 (en) 2003-12-16 2012-10-10 Ipsen Pharma Analogues of glp-1
JP2010538069A (ja) 2007-09-07 2010-12-09 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ エキセンディン−４およびエキセンディン−３の類似体
KR101417873B1 (ko) 2008-08-07 2014-07-09 입센 파마 에스.에이.에스 포도당 의존적인 인슐린 분비 자극성 폴리펩타이드의 유사체
JP2011530509A (ja) 2008-08-07 2011-12-22 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ Ｎ末端において修飾されたグルコース依存性インスリン分泌刺激ポリペプチド（ｇｉｐ）のアナログ
WO2011011072A2 (en) 2009-07-22 2011-01-27 Ipsen Pharma S.A.S. Analogues of insulin-like growth factor-1 (igf-1) having amino acid substitution at position 59

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA953456A (en) * 1970-11-30 1974-08-27 John G. Papalos Leather treating composition and process
US4041223A (en) * 1974-08-30 1977-08-09 Nippon Gohsei Kagaku Kogyo Kabushiki Kaisha Process for preparing hydrolyzed ethylene-vinyl acetate copolymer having improved heat stability
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS59122416A (ja) * 1982-12-29 1984-07-14 Lion Corp 口腔組成物用基材
CH656884A5 (de) * 1983-08-26 1986-07-31 Sandoz Ag Polyolester, deren herstellung und verwendung.
GB8504629D0 (en) * 1984-03-21 1985-03-27 Ici Plc Surfactant
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
US5310879A (en) * 1985-04-30 1994-05-10 The Scripps Research Institute Antibodies which immunoreact with lapine lipopolysaccharide binding protein (LBP)
CA1288881C (en) * 1985-10-04 1991-09-10 Ismael Colon Phosphorylated reaction products and compositions incorporating such products
FR2600894B1 (fr) * 1986-07-02 1989-01-13 Centre Nat Rech Scient Conjugues macromoleculaires d'hemoglobine, leur procede de preparation et leurs applications
JPH07116409B2 (ja) * 1987-05-02 1995-12-13 株式会社バイオマテリアルユニバ−ス 外科用接着剤組成物
US5760015A (en) * 1988-01-19 1998-06-02 The Trustees Of The University Of Pennsylvania Cyclodextrin compounds and methods of making and use thereof
US5183809A (en) * 1990-02-15 1993-02-02 The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation Cyclodextrin polymers and cyclodextrins immobilized on a solid surface
JPH01197500A (ja) * 1988-01-29 1989-08-09 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
DE69030786T2 (de) * 1989-01-27 1998-02-19 Mitsui Toatsu Chemicals Verfahren zur herstellung eines bioverträglichen polyesters
DE69110515T2 (de) * 1990-03-28 1996-02-15 Mitsui Toatsu Chemicals Auf verölten Flächen haftende Heissschmelzklebmasse und eine rutschstabile Verarbeitungsmethode für metallische Blendbleche.
US5143716A (en) * 1991-02-01 1992-09-01 Unger Evan C Phosphorylated sugar alcohols, Mono- and Di-Saccharides as contrast agents for use in magnetic resonance imaging of the gastrointestinal region
KR950002607B1 (ko) * 1991-08-21 1995-03-23 주식회사삼양사 내열성이 우수한 폴리글리콜산의 제조방법
EP0544097A1 (de) * 1991-10-23 1993-06-02 Boehringer Ingelheim Kg Halbfeste Mischungen aus Oligomeren und/oder Polymeren auf der Basis von Milchsäure, Verfahren zur deren Herstellung und deren Verwendung als resorbierbare Implantate
US5672659A (en) * 1993-01-06 1997-09-30 Kinerton Limited Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
EP0678018B1 (en) * 1993-01-06 2003-04-09 Kinerton Limited Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
US5635216A (en) * 1993-12-16 1997-06-03 Eli Lilly And Company Microparticle compositions containing peptides, and methods for the preparation thereof
DE4414138A1 (de) * 1994-04-22 1995-10-26 Consortium Elektrochem Ind Acylierte gamma-Cyclodextrine
CA2193968A1 (en) * 1994-06-28 1996-01-11 Jeffrey G. Clark Ph-modified biocompatible monomer and polymer compositions
DE4435082C1 (de) * 1994-09-30 1996-04-18 Fraunhofer Ges Forschung Verfahren zur Herstellung von Celluloseacetatphosphat oder Celluloseacetatsulfat (Celluloseacetatmischester) mit definierter Molekülstruktur und die Verwendung der erhaltenen Celluloseacetatmischester zur Herstellung von Cellulosephosphat bzw. Cellulosesulfat
CA2167455A1 (en) * 1995-01-19 1996-07-20 Kevin Cooper Absorbable polyalkylene diglycolates
GB9524475D0 (en) * 1995-11-30 1996-01-31 Zeneca Ltd Compound preparation and use

Also Published As

Publication number Publication date
WO2000009166A3 (en) 2000-11-09
EP1105161B1 (en) 2008-04-02
WO2000009166A2 (en) 2000-02-24
NO20010682L (no) 2001-03-27
JP2002522596A (ja) 2002-07-23
PL346758A1 (en) 2002-02-25
ATE390935T1 (de) 2008-04-15
AU5475599A (en) 2000-03-06
CA2339143A1 (en) 2000-02-24
RU2202563C2 (ru) 2003-04-20
DE69938453D1 (de) 2008-05-15
NO20010682D0 (no) 2001-02-09
EP1105161A2 (en) 2001-06-13

Similar Documents

Publication Publication Date Title
ITTO20010060A0 (it) Miscele ternartie di poliesteri alifatici biodegradabili e prodotti da queste ottenuti.
HRP20030648B1 (en) Carrier with solid fibrinogen and solid thrombin
BR0305777A (pt) Composição, e, cápsulas
DE69431121D1 (de) Anti-rauch riechstoffe und kompositionen
DE60108651D1 (de) Wärmegellierende bioabbaubare wässrige polymerlösung
HUP0001299A3 (en) Biodegradable compositions comprising poly(cycloaliphatic phosphoester) compounds and articles
ITMI20001080A0 (it) Contenitore per profumo con generatore di suoni o luce.
DE60043383D1 (de) Adressierbares werbesystem und betriebsverfahren
NZ511631A (en) Vehicular traffic barrier assembly consisting of hinged portions and resilient bumpers at confronting ends of portions
AR020650A1 (es) Polimeros fosforilados y conjugados de los mismos
BR9814743A (pt) Tablete de detergente
DE69916288D1 (de) Lipasehemmer und chitosan enthaltende pharmazeutische zusammensetzungen
PT102290B (pt) Sistema de accionamento de uma porta corredica
DE60008981D1 (de) DPP enthaltende konjugierte Polymere und elektrolumineszente Vorrichtungen
ES2196023T3 (es) Conjugados moleculares ionicos de poliesteres biodegradables y polipeptidos bioactivos.
ATE272677T1 (de) Polymerzusammensetzung mit niedriger emission
ID26982A (id) Komposisi farmasi topiramat
ES2195970T3 (es) L-ribavirina y usos de la misma.
NO20013442D0 (no) Sammensetninger som oppnår en forbedret levering av aktive stoffer
EP1247840A4 (en) BIODEGRADABLE RESIN COMPOSITIONS
DE69111734D1 (de) Phosphor-Überzugszusammensetzung und Entladungslampe.
BR9814227A (pt) Aparelho de refrigeração
ID24828A (id) Komposisi-komposisi farmasi dari tizoksianida dan nitazoksanida
BR0007514A (pt) Macrolìdeos com atividade anti-inflamatória
CY1105805T1 (el) Νεος σχηματισμος

Legal Events

Date Code Title Description
FB Suspension of granting procedure